Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

Co-presentation with both ANCA and anti-GBM antibodies is thought to be relatively rare. Current studies of such ‘double-positive’ cases report small numbers and variable outcomes. To study this further we retrospectively analyzed clinical features and long-term outcomes of a large cohort of 568 con...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Int
Autors principals: McAdoo, Stephen P., Tanna, Anisha, Hrušková, Zdenka, Holm, Lisa, Weiner, Maria, Arulkumaran, Nishkantha, Kang, Amy, Satrapová, Veronika, Levy, Jeremy, Ohlsson, Sophie, Tesar, Vladimir, Segelmark, Mårten, Pusey, Charles D.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2017
Matèries:
Clinical Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5567410/
https://ncbi.nlm.nih.gov/pubmed/28506760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2017.03.014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars